These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21146391)

  • 1. Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.
    Ong DS; Kelly JW
    Curr Opin Cell Biol; 2011 Apr; 23(2):231-8. PubMed ID: 21146391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
    Lindquist SL; Kelly JW
    Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteostasis: bad news and good news from the endoplasmic reticulum.
    Noack J; Brambilla Pisoni G; Molinari M
    Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Approaches for Adapting Proteostasis in the Secretory Pathway to Ameliorate Protein Conformational Diseases.
    Kelly JW
    Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31088828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
    Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
    J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and chemical approaches to diseases of proteostasis deficiency.
    Powers ET; Morimoto RI; Dillin A; Kelly JW; Balch WE
    Annu Rev Biochem; 2009; 78():959-91. PubMed ID: 19298183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Misfolding Diseases and Therapeutic Approaches.
    Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.
    Pey AL
    Amino Acids; 2013 Dec; 45(6):1331-41. PubMed ID: 24178766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping and Exploring the Collagen-I Proteostasis Network.
    DiChiara AS; Taylor RJ; Wong MY; Doan ND; Rosario AM; Shoulders MD
    ACS Chem Biol; 2016 May; 11(5):1408-21. PubMed ID: 26848503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein misfolding in the endoplasmic reticulum as a conduit to human disease.
    Wang M; Kaufman RJ
    Nature; 2016 Jan; 529(7586):326-35. PubMed ID: 26791723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adaptable standard for protein export from the endoplasmic reticulum.
    Wiseman RL; Powers ET; Buxbaum JN; Kelly JW; Balch WE
    Cell; 2007 Nov; 131(4):809-21. PubMed ID: 18022373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of threshold behavior reveals rescue mechanisms of bystander proteins in conformational diseases.
    Sandefur CI; Schnell S
    Biophys J; 2011 Apr; 100(8):1864-73. PubMed ID: 21504722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases.
    Baranczak A; Kelly JW
    Curr Opin Chem Biol; 2016 Jun; 32():10-21. PubMed ID: 26859714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteostasis strategies for restoring alpha1-antitrypsin deficiency.
    Bouchecareilh M; Conkright JJ; Balch WE
    Proc Am Thorac Soc; 2010 Nov; 7(6):415-22. PubMed ID: 21030523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using pharmacological chaperones to restore proteostasis.
    Wang YJ; Di XJ; Mu TW
    Pharmacol Res; 2014 May; 83():3-9. PubMed ID: 24747662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.